Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

NCT05096442 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: GENOSS® DCB
DEVICE: SeQuent® Please NEO

Sponsor

Genoss Co., Ltd.